Drug Shortage Report for SEROQUEL XR

Last updated on 2017-04-27 History
Report ID 2471
Drug Identification Number 02300206
Brand name SEROQUEL XR
Common or Proper name quetiapine fumarate extended-release tablets
Company Name ASTRAZENECA CANADA INC
Active Ingredient(s) QUETIAPINE
Strength(s) 300MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 60 tablets
ATC code N05AH
ATC description ANTIPSYCHOTICS
Reason for shortage Demand increase for the drug.
Anticipated start date 2017-04-24
Actual start date 2017-04-24
Estimated end date 2017-04-26
Actual end date 2017-04-26
Shortage status Resolved
Updated date 2017-04-27
Company comments
Health Canada comments
Company contact information Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2017-04-27 English Compare
v13 2017-04-26 French Compare
v12 2017-04-26 English Compare
v11 2017-04-26 English Compare
v10 2017-04-26 French Compare
v9 2017-04-26 English Compare
v8 2017-04-25 English Compare
v7 2017-04-10 French Compare
v6 2017-04-10 English Compare
v5 2017-04-10 English Compare
v4 2017-04-10 English Compare
v3 2017-04-06 French Compare
v2 2017-04-06 English Compare
v1 2017-03-14 English Compare